Literature DB >> 939232

ALPHA-Amylase activity in sweat and serum of patients with cystic fibrosis of the pancreas.

W P Nikolaejek, H M Emrich.   

Abstract

The hypothesis by Doggett and Harrison, according to which alpha-amylase is the pathogenic factor of the exocrinopathy in cystic fibrosis (C.F.), is investigated. No elevation of alpha-amylase in sweat and serum of C.F. patients, as compared with controls of similar age, is observed. It is concluded that the "C.F. factor" cannot be identified with alpha-amylase.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 939232     DOI： 10.1007/bf00481509

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  5 in total

1.  A sodium transport inhibitory factor in the saliva of patients with cystic fibrosis of the pancreas.

Authors:  J A Mangos; N R McSherry; P J Benke
Journal:  Pediatr Res       Date:  1967-11       Impact factor: 3.756

2.  Cystic fibrosis: in vivo reversal of the ciliostatic character of serum and parotid secretions by heparin.

Authors:  R G Doggett; G M Harrison; T A Patrick
Journal:  Nat New Biol       Date:  1973-06-20

3.  Studies on the mechanism of inhibition of sodium transport in cystic fibrosis of the pancreas.

Authors:  J A Mangos; N R McSherry
Journal:  Pediatr Res       Date:  1968-09       Impact factor: 3.756

4.  [Separation of different compounds in sweat, depending upon sweat flow rate].

Authors:  H M Emrich; K J Ullrich
Journal:  Pflugers Arch Gesamte Physiol Menschen Tiere       Date:  1966

5.  Sodium transport: inhibitory factor in sweat of patients with cystic fibrosis.

Authors:  J A Mangos; N R McSherry
Journal:  Science       Date:  1967-10-06       Impact factor: 47.728
  5 in total
  1 in total

1.  Ultramicro-electrophoresis of protein in sweat from patients with cystic fibrosis of the pancreas and controls.

Authors:  C P Schröder; H M Emrich
Journal:  Eur J Pediatr       Date:  1978-05-22       Impact factor: 3.183
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.